Today: 21 May 2026
ASML stock ends week higher on Barclays upgrade as investors weigh rich valuation and looming dividend
1 February 2026
1 min read

ASML stock ends week higher on Barclays upgrade as investors weigh rich valuation and looming dividend

Amsterdam, January 31, 2026, 23:46 (CET) — Market closed.

  • After a volatile week and new analyst upgrades, ASML shares finished Friday on an upswing.
  • Bulls highlight AI-driven demand and record-breaking orders; sceptics focus on capacity constraints and stretched valuations.
  • Keep an eye on the February dividend and the annual report expected late in the month.

ASML shares in Amsterdam ended Friday’s session up 1.98%, closing at 1,215.60 euros. That puts the stock roughly 3% higher over the last five days, based on market data.

Markets are closed for the weekend, shifting focus to Monday’s open and the question of whether January’s momentum will extend into February. ASML stands out for many investors as a straightforward play on chip spending linked to data centres and AI, avoiding the need to choose between chipmakers.

The trade is looking crowded. Reuters noted the stock has jumped 34% this month and now trades at roughly 42 times 2026 earnings estimates after a volatile earnings reaction. Han Dieperink at Aureus said much of the good news “is already priced in.” According to the same Reuters story, ASML’s order backlog stands at 38.8 billion euros, with its extreme ultraviolet (EUV) machines—the tools used to print the smallest circuits—taking about a year to build. Degroof Petercam analyst Michael Roeg cautioned that upgrades might slow, a scenario that could make investors “question the risk-reward” on these high multiples. Reuters

Barclays fired up the market on Thursday by upgrading ASML to overweight. The firm highlighted record orders as reason enough for “material upgrades” to its estimates, according to a note cited by Visible Alpha. Analyst Simon Coles bumped his price target to 1,500 euros from 1,200, citing AI-driven demand and a higher 2026 revenue forecast. Meanwhile, ASML revealed plans to slash about 1,700 jobs. Investing.com

Other brokers have lifted their targets as well. Berenberg analyst Tammy Qiu bumped her price target up to 1,500 euros from 1,300, maintaining a buy rating, according to MarketScreener.

The real issue emerges when upgrades no longer drive growth. Investors have counted on ASML and peers like Applied Materials, Lam Research, and Tokyo Electron to navigate the capex cycle without depending on a single chip designer or foundry.

The downside scenario isn’t complicated. If orders take longer to turn into shipments, or if customers cut back on tool spending after a strong start, the stock’s valuation could suffer sharply. Renewed export tensions with China would only add to the pressure.

The company plans to release its 2025 annual report on February 25, with first-quarter 2026 results due April 15.

Income-focused investors have a closer date to watch: ASML’s interim dividend goes ex-dividend on February 9 in Europe, and February 10 for U.S. shareholders. The payment is scheduled for February 18, per the company’s timeline.

Stock Market Today

  • Bitmine Immersion Technologies Uplists to NYSE, Holds 5M+ ETH as Ethereum Proxy, Launches MAVAN Staking
    May 21, 2026, 12:11 AM EDT. Bitmine Immersion Technologies (NYSE:BMNR) has become a major Ethereum proxy by accumulating over 5 million ETH, representing more than 4.3% of Ethereum's total supply. The company uplisted to the NYSE and introduced MAVAN, an institutional-grade Ethereum staking platform, shifting its focus beyond mining to include staking services. BMNR stock closed at $19.39, trading below analyst targets and experiencing recent price declines despite longer-term gains. Investors should watch Ethereum price trends, staking yields, and institutional adoption of MAVAN, while noting BMNR remains loss-making and has diluted shareholders.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Abbott Laboratories stock price: ABT ends Friday up 3% — what investors watch next week
Previous Story

Abbott Laboratories stock price: ABT ends Friday up 3% — what investors watch next week

Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings
Next Story

Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings

Go toTop